form (which includes a native PPant modification), cannot be further modified directly with another PPant tag. To overcome these difficulties, we use ACP hydrolase (AcpH), a phospho diesterase from Pseudomonas aeruginosa 13 , and Sfp, a PPTase from Bacillus subtilis 14 , to swap different PPantconjugated small mole cules on free ACP and ACP fusion proteins (Fig. 1) . This reversible tagging system offers the ability to connect synthetic and biological chemistry with ease and provides uniformly labeled, highquality ACP and ACP fusion proteins, as demonstrated here through fluorescence labeling and solutionphase protein NMR.
For evaluation of iterative labeling, we began with fluorescent ACP labeling directly in cellular lysate (Supplementary Fig. 1a ) from E. coli strain DK554, which overexpresses native fatty acid ACP (AcpP) in predominantly apo form. Treatment of this lysate with coumarinCoA and Sfp generated a blue fluorescent band upon excitation of SDSPAGE samples at 254 nm that comigrated with a coumarinlabeled ACP standard. Subsequent treatment of coumarinlabeled lysate with recombinant AcpH uniformly removed the coumarinPPant from ACP, as demonstrated by the disappearance of the blue band ( Supplementary Fig. 1b) . Subsequent treatment of the sample with Sfp and rhodamineCoA generated a new red fluorescent SDSPAGE band upon excita tion at 532 nm ( Supplementary Fig. 1c) ; this label can also be removed ( Fig. 2a and Supplementary Fig. 2a ) with AcpH.
After demonstrating the compatibility of AcpH for removing various PPant analogs, we sought to demonstrate the flexibility of our technique by evaluating interaction with ACP fusion proteins. AcpH removed rhodaminePPant from ACP attached to three different fusion partners: an Nterminal maltosebinding protein (MBP), a Cterminal GFP and an Nterminal bacterial luciferase fusion (LuxACP) ( Fig. 2b and Supplementary Figs. 2b,c, 3 and 4) . The activity of the luciferaseACP fusion did not change nota bly following label manipulation ( Supplementary Fig. 5 ).
reversible labeling of native and fusion-protein motifs
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the reversible covalent attachment of chemical probes to proteins has long been sought as a means to visualize and manipulate proteins. here we demonstrate the full reversibility of post-translational custom pantetheine modification of Escherichia coli acyl carrier protein for visualization and functional studies. We use this iterative enzymatic methodology in vitro to reversibly label acyl carrier protein variants and apply these tools to nmr structural studies of protein-substrate interactions.
Posttranslational protein modification is important for adding functions to proteins that can be exploited for therapeutics 1 , pro tein engineering 2 , affinity design 3 and enzyme immobilization 4 , among other applications 5 . Acyl carrier protein (ACP) labeling with 4′phosphopantetheine (PPant), conjugated to a tag of choice by its transferase (PPTase), represents one of the most flexible covalent protein labeling methods, as illustrated by its application in tagging minimalACP peptides 6 , biogel formation 7 and ACPdependent protein immobilization 8 . The labeling of ACP and ACP fusion proteins with PPant analogs is also successfully leveraged for visu alization 9 , isolation 9,10 and functional 11 and structural 12 studies of carrier protein-dependent biosynthetic enzymes. Yet, fur ther advancement of these tools is hampered by an inability to easily reverse PPant attachment. Naturally occurring ACPs, often isolated in holo 
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We additionally found that labeling of the GFPACP fusion with rhodamineCoA generates an observable Förster resonance energy transfer (FRET) signal ( Supplementary Fig. 6 ), which enables observation of AcpH or PPTase activity in a simple and scalable assay format. Recent studies of fatty acid and polyketide pathways focus on the extent and function of substrate sequestration by ACP, in which the growing acyl chain is covalently attached via a thioester linkage to the terminus of posttranslationally added 4′phosphopantetheine 15 . Biosynthetic intermediates with var ied chemical structures participate in intramolecular interactions with ACP that modulate substrate dynamics and ACP structure 16 . The nature of these ACPsubstrate interac tions depends on the chemical structure of the biosynthetic intermediate and can vary with respect to chain length and oxidation state 17 . Furthermore, observa tions of this phenomenon appear to vary depending on the analytical method used. Xray crystallography of hexanoyl-, heptanoyl-and decanoyl-ACPs from E. coli fatty acid biosynthesis all show the acyl chain clearly buried in ACP 18 , whereas two different crystal forms of butanoyl-ACP show the acyl chain residing outside the protein with one form and inside the pro tein with the other 19 . NMR studies have shown that shortchain polyketide analogs protrude into solution when appended to Streptomyces coelicolor actinorhodin ACP, whereas saturated acyl chains of 4-8 carbons associate more closely with this polyketide ACP 16 . Variations in substrate dynamics must clearly play a role in the catalytic processivity of these synthases, and we hypothesize that the dynamics of substrate binding serves a critical function in substrate specificity.
To evaluate substrate dynamics with respect to substrate identity, it is neces sary to perform multiple studies on the same protein with varying acyl substrates covalently attached. Given the labor and expense of preparing uniformly labeled, isotopeenriched proteins for NMR struc tural studies, we investigated the use of AcpH as a means to recycle 15 Nenriched ACP. We reversibly labeled a single sample of 15 Nenriched E. coli ACP with several acyl pantetheine analogs and character ized the dynamics of the acyl-[ 15 N]ACP species with NMR spectroscopy. By incor porating fatty acyl pantetheines with 13 C labels within the acyl chain, we directly observed intramolecular interactions of the [ 15 N]ACP with the pendant acyl chain using nuclear Overhauser effect (NOE) measurements.
We evaluated [ 15 N]ACP at each labeling conformation via gel ( Fig. 2c and Supplementary Figs. 7 and 8) and NMR analysis ( Supplementary Figs. 9-14 ). We obtained an initial apo and holo mixture following E. coli expression that required full conversion to the apo form using AcpH. Subsequent conversion to octanoyl[ 15 N]ACP used the chemoenzymatic syn thesis of an octanoylCoA analog with Sfp labeling 14 (Fig. 2c) . After NMR evaluation, we converted the [ 15 N]ACP back to the apo form with AcpH for subsequent relabeling. We acquired 15 npg of acyl chain sequestration in the hydrophobic binding pocket 20 . Conversion from this acylated form back to the apo form by AcpH provided uniformly unlabeled apo-[ 15 N]ACP, as confirmed by an HSQC spectrum of the regenerated protein that identically matched that of the original (Fig. 3b) . This validated the feasibil ity of reversible ACP labeling, as it demonstrated that the regener ated apo[ 15 N]ACP is properly folded and ready for subsequent modification. We next labeled this regenerated apo-[ 15 N]ACP with a [ 13 C 4 ]butanoylCoA analog ( Fig. 2c) , which contained 13 Fig. 15 ). This result was likely produced from spatial proximity of an aliphatic proton in a [ 15 N]ACP side chain and the 13 CH 3 group in the [8 13 C 1 ]octanoyl acyl chain, indicating that the longer acyl chain resides in the protein binding pocket. This finding signifies a lack of dynamic mobility and seques tration of the acyl chain. Conversely, the negative result from [ 13 C 4 ]butanoyl[ 15 N]ACP indicates that the shorter acyl chain is notably more dynamic in solution. The Xray crystal structure indicates two states for a tethered butanoyl substrate: one outside (evidenced by a closed hydrophobic pocket) and one sequestered within the protein 19 . Our NMRbased finding highlights the dif ferences of substratetethered ACP behavior between solution and crystalline structure and reveals that the solutionexposed acyl chain is the predominant form of [ 13 C 4 ]butanoyl[ 15 N]ACP in solution. We conclude that analysis of ACPsubstrate dynamics must necessarily be performed in the solution state.
In addition to observing the dynamics of tethered acyl sub strates, these NMR studies provide a qualitative evaluation for protein quality after repeated labeling and unlabeling steps.
This demonstration offered an ideal testing ground for the reversible labeling method, as we used only one isotopeenriched protein sample for the entire experiment. Any protein degrada tion or incomplete reactivity would severely compromise the quality of resulting NMR spectra. To provide quality control, we acquired HSQC spectra of purified [ 15 N]ACP at each discrete step throughout the process and compared them to the spectra of the original apo[ 15 N]ACP sample ( Fig. 3) , which revealed retention of protein integrity throughout the experiment. By tracking the ultraviolet absorbance of [ 15 N]ACP throughout all conversions (Supplementary Table 1) , we observed a final recovery of 27% protein after five discrete enzymatic reaction steps. We further evaluated reaction efficiency for all presented reactions ( Table 1 and Supplementary Figs. 16 and 17) ; the values demonstrate that twostep yields above 60% are feasible for most ACP constructs.
This work suggests that AcpH is capable of removing a broad variety of covalently tethered labels beyond those studied here, in addition to accommodating N and Cterminal ACP fusion partners with ease. Given the multitude of existing opportunities for ACP labeling, particularly in work involving fusionprotein applications and naturalproduct biosynthetic studies, we believe that providing a reversible methodology will provide markedly improved flexibility for rapid modification of protein species. Additionally, the costsaving measure of recovering valuable apoACP substrates cannot be overlooked. Because of the wide pantetheine substrate acceptance demonstrated by a combined Sfp and AcpH methodology, various fluorescent and functional tags can be exchanged on a single protein with robustness not offered by previous enzymatic methods.
methods
Methods and any associated references are available in the online version of the paper.
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npg nature methods doi:10.1038/nmeth.2175 online methods Determination of protein concentration, protein gels, miscellaneous. ACP concentrations were determined by UV absorbance measurements at 280 nm unless otherwise noted. Extinction coef ficients were calculated using the ExPASy (http://www.expasy.ch/) ProtParam tool: E. coli free ACP = 1,490 M −1 cm −1 , GFPACP = 69,000 M −1 cm −1 , MBPPaACP = 66,000 M −1 cm −1 and LuxACP = 85,720 M −1 cm −1 . NonACP protein concentrations and fusion ACPs used in the efficiency analysis (Table 1b) were determined using the Bradford method against a BSA standard. ACP was run on 20% 2 M ureaPAGE to resolve apo, holo and crypto conver sions as well as 12% SDSPAGE to evaluate overall purity during NMR workup. ACP fusions MBPPaACP and GFPACP samples were run on 15% 2 M ureaPAGE and LuxACP was run on 10% SDSPAGE for fluorescence imaging experiments. Electrophoresis of fluorescent coumarin and rhodamine nonfusion E. coli ACP modifications used 10% Tristricine SDSPAGE.
Gel imaging. Coomassiestained gels were imaged on a FluorS MultiImager (BioRad) using visible light exposure. Coomassie gel images were acquired as .tiff files, and excess white was discarded using the Auto Levels feature of Photoshop (Adobe). UV acquisition was also performed on the FluorS MultiImager, with short/long wave UV and a 520LP filter, and excess black was discarded using the Auto Levels feature of Photoshop (Adobe). GFP fluorescence imaging before gel fixing was performed on a UVP BioSpectrum (UVP LLC) system with a SYBR Green 515 to 570nm-emission filter. Excitation was provided by transillumi nation from a UVP BioLite with a 420BP40 filter. GFP fluores cence images were collected as .tiff files and had gray input levels adjusted using Photoshop from '0,1.00,255' to '0,1.00,150' to dis card excess black. Rhodaminelabeled protein gels were imaged on a Typhoon (GE Healthcare) gel scanner at 50µm resolution with a photomultiplier tube (PMT) setting of 450 and using a 532nm (green laser) excitation and 580BP30 emission filter. Typhoon gel images were collected as .gel files, converted to .tiff in ImageJ (NIH) and exported to Photoshop, with which gray input levels were adjusted from '0,1.00,255' to '80,1.00,255' to discard excess whites collected from the .gel file. All gels, with the exception of GFPACP containing gels, were fixed with 10% acetic acid, 40% methanol and 50% water for 1 h, then rinsed three times with water before UV fluorescence imaging and subsequent staining. GFPACP images were acquired before gel fixing, after which they were fixed and imaged as other gels. Methods and Supplementary Table 2 . For expression of E. coli [ 15 N]ACP, E. coli BL21 (DE3) cells containing plasmid pET22b encoding Cterminal 6×Histagged E. coli ACP were cultured in 1 L M9 minimal medium supplemented with 1 g/L 15 Nenriched ammonium chloride and 100 µg/mL ampicillin. Culture was grown to OD 600 = 0.6, induced with 1 mM IPTG and was shaken 4 h at 37 °C. E. coli BL21(DE3) cells containing the MBPAcpH plasmid were grown in 1 L LB, 0.2% Dglucose and 50 µg/mL kanamycin sulfate at 37 °C to OD = 0.6, induced with 1 mM isopropyl βd 1thiogalactopyranoside (IPTG), and shaken at 16 °C overnight. Medium was centrifuged 30 min at 2,000 r.p.m. to pellet cells. Cell pellets were stored at −20 °C overnight. AcpH6×His construct was grown similarly without glucose. Cells were thawed on ice and suspended in lysis buffer (50 mM TrisCl, pH 8; 500 mM NaCl; and 10% glycerol) with additional ingredients 0.1 mg/mL lysozyme, 0.1 mM DTT, 5 µg/mL DNase I and 5 µg/mL RNase A and passed twice through a French pressure device at 1,000 p.s.i. Lysate was centrifuged 45 min at 10,000 r.p.m., and supernatant was incu bated with amylose resin (New England Biolabs) for MBPAcpH or with NiNTA (Novagen) for AcpH6×His according to manu facturer protocols. Eluted MBPAcpH was then concentrated to 10 mg/mL and subsequently FPLCpurified with 50 mM TrisCl and 250 mM TrisCl, pH 8.0, buffers to remove contaminating native E. coli MBP. MBPAcpH was concentrated with a 10kDa Amicon spin filter (Millipore) and stored in 40% glycerol at −80 °C after flash freezing aliquots in liquid nitrogen. 6×HisAcpH was lysed in a similar manner, but it was purified with NiNTA resin (Novagen). NiNTA resin with bound protein was washed with 10 mM imidazole and eluted with 300 mM imidazole in lysis buffer. 6×HisAcpH was desalted to remove imidazole and flash frozen at −80 °C at 1 mg/mL without further modification. MBPPaACP and LuxACP were expressed in E. coli BL21 (DE3) in LB with 50 µg/mL kanamycin. GFPACP (6×Histagged in pCA24N vector) 21 was expressed in E. coli K12 strain AG1 (ASKA library) cells in LB with 20 µg/mL chloramphenicol. Cells containing fusion ACPs were grown, induced and purified in an otherwise identical manner to 6×Histagged AcpH. MBP and GFP fusion ACPs eluted with 300 mM imidazole were dialyzed into AcpH reaction buffer without Mg 2+ or Mn 2+ cofactors overnight. Lux ACP was buffer exchanged using a PD10 desalting column (GE Healthcare) into AcpH reaction buffer, flash frozen and stored overnight at −80 °C. LuxACP was thawed on ice, AcpH was added to 5 µM and the reaction was incubated at 37 °C for 4 h. Dialyzed ACP fusions next had appropriate amounts of 1 M MgCl 2 and MnCl 2 added to achieve 15 mM and 1 mM final concentrations, respectively. Free AcpH was added to free ACP and to MBP and GFP fusion ACPs at 5 µM final concentration, and the mixture was incubated overnight at 37 °C in a rotary wheel. LuxACP was reacted for 4 h at 37 °C. ACP reactions were centrifuged to remove any precipitate and purified by anionexchange chromatography. Purity evaluation was conducted on MBPPaACP and GFPACP (Supplementary Fig. 3 ) as well as on LuxACP ( Supplementary  Fig. 4 ) with SDSPAGE.
Production of AcpH and recombinant ACP constructs. Cloning methods and primers are contained in the Supplementary
Preparation of coumarin-ACP standard. E. coli DK554 cells were grown, induced and prepared to generate predominantly apoACP. Isopropanol supernatant containing ACP was applied to DEAE resin and eluted with a sodium chloride gradient. ACP was then labeled using 6×HisSfp and coumarinCoA. Sfp was removed with NiNTA resin, and excess coumarinCoA was removed with sizeexclusion chromatography on G25 Sephadex resin.
Preparation of E. coli DK554 lysate. 50 mL LB medium supple mented with 25 µM calcium dpantothenate, 50 mM dglucose and 50 µg/mL kanamycin used previously 22 . Medium was inocu lated with 1 mL of overnight DK554 starter culture and grown to OD = 0.4. IPTG was added at a concentration of 1 mM to the medium and was shaken for 5 h at 37 °C. Medium was centri fuged at 4,000 r.p.m. at 4 °C for 30 min to pellet cells. Cell pellets were resuspended in 25 mM TrisCl, pH 7.5; 250 mM NaCl; 0.1 mg/mL lysozyme; 10 µM pepstatin; and 10 µM leupeptin and passed twice through a French pressure device at 1,000 p.s.i. Lysate was centrifuged 45 min at 10,000 r.p.m. and 4 °C to remove insoluble debris.
Removal of coumarinpantetheine from ACP in 5 mL lysate was achieved using 10 µM MBPAcpH fusion in 600 mL AcpH reaction buffer (50 mM TrisCl, pH 8.0; 100 mM NaCl; 10% glyc erol; 15 mM MgCl 2 ; and 1 mM MnCl 2 ) within a 3kDaMWCO dialysis bag at 37 °C overnight.
Fluorescence labeling of E. coli DK554 lysate with modified coenzyme A. E. coli DK554 cell lysate with total protein concen tration of approximately 2 mg/mL was added to the volume of premade 10× PPTase reaction buffer (500 mM NaHEPES and 100 mM MgCl 2 , pH 7.6) that brought the total reaction con centration to 50 mM NaHEPES, pH 7.6; 10 mM MgCl 2 ; 5 µM coumarinCoA 23 ; and 2 µM Sfp. Samples were incubated at 37 °C for 1 h and then centrifuged to remove precipitate. Supernatant was passaged over an equilibrated G50 Sephadex (GE Healthcare) desalting column, and lysate was dialyzed using 3.5kDa MWCO membrane into 50 mM TrisCl, pH 8.0; 100 mM NaCl; and 10% glycerol to further remove unreacted CoA analog.
AcpH treatment of coumarin-ACP in lysate. Coumarinlabeled DK554 celllysate supernatant was added to a freshly prepared 10× AcpH reaction buffer to generate the following reaction concen trations: 50 mM TrisCl, pH 8; 150 mM NaCl; 15 mM MgCl 2 ; and 1 mM MnCl 2 . MBPAcpH was added to 2 µM. Reaction contents were placed in a 3.5kD MWCO dialysis membrane and dialyzed against 50fold volume of reaction buffer stirred overnight at 37 °C. No remaining coumarinACP fluorescence was observed, and a substantial amount of MBPAcpH appeared as precipitate afterward, as determined by SDSPAGE analysis (not shown). Postreaction contents were centrifuged 30 min at 4,000 r.p.m. at 6 °C. Supernatant was dialyzed back into 50 mM TrisCl, pH 7.5, and 250 mM NaCl in preparation for rhodamine labeling.
Sfp and AcpH treatment of purified rhodamine-ACP.
The demonstrated activity of AcpH on rhodamineACP was performed with previously purified 6×Histagged apoACP. First, 7 nmol of apoACP was treated with 5 µM native Sfp and 24 nmol of rhodamineCoA 24 in 50 mM TrisCl, pH 8; 100 mM NaCl; and 10 mM MgCl 2 at 37 °C for 1 h. RhodamineACP was repurified with NiNTA resin to remove excess rhodamineCoA and Sfp and dialyzed to remove imidazole. Dialyzed rhodamineACP was then incubated with and without 7 µM AcpH at 37 °C for 2 h, and the resulting crude reactions were run on SDSPAGE and imaged to illustrate fluorescentlabel removal with AcpH.
AcpH treatment of [ 15 N]ACP for NMR study. An AcpH reaction was conducted to generate each apo[ 15 N]ACP sample before labeling. Following NMR acquisition of each sample, ACP was dialyzed into AcpH reaction buffer without cofactors (50 mM TrisCl, pH 8.0 and 100 mM NaCl). Glycerol was found to be unnecessary for desired AcpH activity and was omitted. Following dialysis, MgCl 2 and MnCl 2 were added to achieve a final con centration of 15 mM and 1 mM, respectively. Free 6×His AcpH was added to a concentration of 5-10 µM, and the mixture was incubated at 37 °C for 8 h. Reaction completion was determined by ureaPAGE analysis. The completed reactions were centrifuged 30 min at 4,000 r.p.m. at 6 °C to remove precipitate. ACP anion-exchange purification. All preparative ACP samples were dialyzed into lowsalt buffer. E. coli ACP and MBPPaACP ionexchange running buffer was 25 mMLhistidine, pH 6.0. GFPACP and LuxACP ionexchange buffer was 25 mM bis Tris, pH 6.0. Samples were then applied to a DEAE HiTrap (GE Healthcare) 1mL or 5mL column. Free ACP, MBPACP and GFPACP were loaded onto columns and washed with 10 mL of 25 mM buffer containing 25 mM NaCl and were eluted with 5 mL of 25 mM buffer and 500 mM NaCl. LuxACP was loaded onto a 5mL DEAE HiTrap and washed with a step gradient of 0, 100, 200, 300 and 500 mM NaCl in 25 mM bisTris, pH 6.0. NMR E. coli [ 15 N]ACP samples were then dialyzed into 100 mM sodium phos phate and 1 mM DTT, pH 7.4, and then concentrated to 450 µL before NMR acquisition. E. coli [ 15 N]ACP NMR sample purity was evaluated by SDSPAGE analysis (Supplementary Fig. 8) . Following ion exchange, fusion ACPs were dialyzed or desalted, spin concentrated and stored at −80 °C before further use.
Labeling of [ 15 N]ACP using 'one
Fusion ACP rhodamine-CoA labeling and label removal.
Purified apoMBPPaACP at 200 µM was labeled with 1 mM rhodamineCoA and 13 µM native Sfp for 3 h at 37 °C. Purified apoGFPACP at 150 µM was labeled with 1 mM rhodamine CoA and 7 µM native Sfp for 3 h at 37 °C. Purified apoLuxACP at 12 µM was labeled with 50 µM rhodamineCoA and 3 µM native Sfp for 1 h at 37 °C. Fusion ACPs were then repurified from excess rhodamineCoA and native Sfp using NiNTA resin, buffer exchanged, and concentrated using 10kDa MWCO 0.5 mL Amicon spin filters (Millipore). Label removal of MBPACP and GFPACP proceeded with 4 µL of the concentrated crypto fusion ACPs with 10 µM AcpH in 10 µL AcpH reaction buffer for 3 h at 37 °C. For LuxACP, 6 µM cryptoLuxACP was reacted with 5 µM AcpH for 3 h at 37 °C. AcpH reaction samples were run immediately afterward on ureaPAGE (MBPACP and GFPACP) or SDSPAGE (LuxACP) with no further purification.
Sfp and AcpH treatment of E. coli ACP and fusion ACPs for efficiency analysis. Labeling of butanoyl, octanoyl and coumarin ACP proceeded via Sfp and CoAA/D/E onepot methodology. Labeling of free ACP and fusion ACPs with rhodamine proceeded via Sfp and rhodamineCoA. Free E. coli ACP reactions were conducted overnight at 37 °C. MBPPaACP labeling proceeded via native Sfp; GFPACP and luciferaseACP reactions using Sfp conjugate proceeded for 6 h at 37 °C. MBPPaACP was repurified npg
